Advertisement

Ads Placeholder
Loading...

Cann Group Limited

CAN.AXASX
Healthcare
Drug Manufacturers - Specialty & Generic
$0.006
$0.00(0.00%)
Australian Market opens in 60h 25m

Cann Group Limited Fundamental Analysis

Cann Group Limited (CAN.AX) shows moderate financial fundamentals with a PE ratio of 0.34, profit margin of 1.30%, and ROE of 93.89%. The company generates $0.0B in annual revenue with weak year-over-year growth of -13.79%.

Key Strengths

ROE93.89%
Cash Position19.00%
PEG Ratio0.00

Areas of Concern

Operating Margin-97.39%
Current Ratio0.42
We analyze CAN.AX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 38.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
38.9/100

We analyze CAN.AX's fundamental strength across five key dimensions:

Efficiency Score

Excellent

CAN.AX demonstrates superior asset utilization.

ROA > 10%
26.52%

Valuation Score

Excellent

CAN.AX trades at attractive valuation levels.

PE < 25
0.34
PEG Ratio < 2
0.00

Growth Score

Moderate

CAN.AX shows steady but slowing expansion.

Revenue Growth > 5%
-13.79%
EPS Growth > 10%
61.55%

Financial Health Score

Moderate

CAN.AX shows balanced financial health with some risks.

Debt/Equity < 1
0.44
Current Ratio > 1
0.42

Profitability Score

Weak

CAN.AX struggles to sustain strong margins.

ROE > 15%
93.89%
Net Margin ≥ 15%
1.30%
Positive Free Cash Flow
No

Key Financial Metrics

Is CAN.AX Expensive or Cheap?

P/E Ratio

CAN.AX trades at 0.34 times earnings. This suggests potential undervaluation.

0.34

PEG Ratio

When adjusting for growth, CAN.AX's PEG of 0.00 indicates potential undervaluation.

0.00

Price to Book

The market values Cann Group Limited at 0.15 times its book value. This may indicate undervaluation.

0.15

EV/EBITDA

Enterprise value stands at 1.34 times EBITDA. This is generally considered low.

1.34

How Well Does CAN.AX Make Money?

Net Profit Margin

For every $100 in sales, Cann Group Limited keeps $1.30 as profit after all expenses.

1.30%

Operating Margin

Core operations generate -97.39 in profit for every $100 in revenue, before interest and taxes.

-97.39%

ROE

Management delivers $93.89 in profit for every $100 of shareholder equity.

93.89%

ROA

Cann Group Limited generates $26.52 in profit for every $100 in assets, demonstrating efficient asset deployment.

26.52%

Following the Money - Real Cash Generation

Operating Cash Flow

Cann Group Limited generates limited operating cash flow of $-4.32M, signaling weaker underlying cash strength.

$-4.32M

Free Cash Flow

Cann Group Limited generates weak or negative free cash flow of $-4.48M, restricting financial flexibility.

$-4.48M

FCF Per Share

Each share generates $-0.01 in free cash annually.

$-0.01

FCF Yield

CAN.AX converts -1.25% of its market value into free cash.

-1.25%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

0.34

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.003

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.15

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.38

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.44

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.42

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.94

vs 25 benchmark

ROA

Return on assets percentage

0.27

vs 25 benchmark

ROCE

Return on capital employed

-0.32

vs 25 benchmark

How CAN.AX Stacks Against Its Sector Peers

MetricCAN.AX ValueSector AveragePerformance
P/E Ratio0.3428.54 Better (Cheaper)
ROE93.89%738.00% Weak
Net Margin130.29%-43982.00% (disorted) Strong
Debt/Equity0.440.34 Weak (High Leverage)
Current Ratio0.422806.01 Weak Liquidity
ROA26.52%-14624.00% (disorted) Strong

CAN.AX outperforms its industry in 3 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Cann Group Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

455.82%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

64.19%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

85.14%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ